Solter P F, Hoffmann W E, Chambers M D, Schaeffer D J, Kuhlenschmidt M S
Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign 61801.
Am J Vet Res. 1994 Aug;55(8):1086-92.
High serum alkaline phosphatase (ALP) activity is considered a sensitive marker of cholestasis in most mammalian species, including dogs. Induction of high serum ALP activity in association with cholestasis is dependent on high hepatic bile acids concentrations. Treatment of dogs with glucocorticoids also results in high serum ALP activity. The possible causal relation between serum ALP activity and bile acids concentration was investigated in dogs treated with glucocorticoids. The relation of glucocorticoid treatment to changes in the activity of individual ALP isoenzymes, alanine transaminase (ALT) and gamma-glutamyltransferase (GGT) also was investigated. Eight conditioned dogs were given 4 mg of prednisone/kg of body weight, i.m., daily for 10 days. Blood samples were taken prior to treatment and on treatment days 3, 5, 7, and 10. Liver tissue was then taken from each dog. Serum total ALP activity was significantly (P < 0.05) high at day 3 in prednisone-treated dogs. Isoenzyme analysis indicated that this increase was attributable to an increase in the liver ALP isoenzyme (LALP). Significant increases in serum corticosteroid-induced ALP (CALP) and bone ALP were first observed on days 7 and 10, respectively. Serum ALT and GGT activities were significantly increased by day 5. Increased serum or hepatic tissue bile acids concentrations were not observed in prednisone-treated dogs, compared with values in 8 clinically normal (control) dogs, but were high in 3 dogs with complete bile duct ligation. Hepatic activities of LALP, CALP, and GGT were higher in prednisone-treated dogs than values in controls, indicating probable increased hepatic synthesis of these enzymes. Hepatic ALT activity was not increased.(ABSTRACT TRUNCATED AT 250 WORDS)
在包括犬类在内的大多数哺乳动物中,高血清碱性磷酸酶(ALP)活性被认为是胆汁淤积的敏感标志物。与胆汁淤积相关的高血清ALP活性的诱导取决于高肝胆汁酸浓度。用糖皮质激素治疗犬类也会导致高血清ALP活性。在接受糖皮质激素治疗的犬类中,研究了血清ALP活性与胆汁酸浓度之间可能的因果关系。还研究了糖皮质激素治疗与个体ALP同工酶、丙氨酸转氨酶(ALT)和γ-谷氨酰转移酶(GGT)活性变化之间的关系。八只条件适宜的犬每天肌肉注射4mg泼尼松/千克体重,持续10天。在治疗前以及治疗第3、5、7和10天采集血样。然后从每只犬身上获取肝脏组织。泼尼松治疗的犬在第3天时血清总ALP活性显著升高(P<0.05)。同工酶分析表明,这种升高归因于肝脏ALP同工酶(LALP)的增加。血清皮质类固醇诱导的ALP(CALP)和骨ALP分别在第7天和第10天首次出现显著增加。血清ALT和GGT活性在第5天时显著升高。与8只临床正常(对照)犬的值相比,泼尼松治疗的犬未观察到血清或肝组织胆汁酸浓度升高,但3只完全胆管结扎的犬胆汁酸浓度较高。泼尼松治疗的犬肝脏中LALP、CALP和GGT的活性高于对照组,表明这些酶的肝脏合成可能增加。肝脏ALT活性未增加。(摘要截断于250字)